CSF, PET, and Blood-Based Biomarker Tests for Alzheimer Disease - Part 2

In this series, Suzanne Schindler, MD, PhD, Associate Professor of Neurology at Washington University School of Medicine in St. Louis, discusses cerebrospinal fluid, PET, and blood-based biomarker tests for Alzheimer disease, including factors influencing the selection of these tests and recommendations for physicians when communicating test results with their patients. In this episode, Dr. Schindler presents an overview of factors influencing the selection of cerebrospinal fluid, PET, and blood-based biomarker tests. Learn more about your ad choices. Visit megaphone.fm/adchoices